🛸Only 3 days left if you want to give a short talk at our inaugural Barts RNA Cancer symposium on 15th June in London at Barts Cancer Institute (Queen Mary). Great lineup of world-renown speakers! Please RT and register here👇👇👇👇

Thank you all for registering to attend the Barts RNA Cancer symposium. We had huge interest and the event has now been oversubscribed and therefore the registration is now closed. We will be soon communicating more details on the finalised programme! Stay tuned! Barts Cancer Institute (Queen Mary)

Check out our Nature Cell Biology N&Vs discussing the latest findings by Dou et al on the identification of a novel non-coding m6A reader (RBFOX2), with potential therapeutic implications in leukemia!! 👇🏻👇🏻🔥🔥 nature.com/articles/s4155…

Very much looking forward to this exciting meeting!

We are excited to share pre-clinical and some early clinical data for inobrodib which looks encouraging for patients with blood cancer cell.com/cancer-cell/fu…

A great first day as a new Group Leader & Centre Director The ICR presenting our work on targeting mRNA modifications in AML at the Keystone RNA modifications symposium. Looking forward to setting up the new lab when I get back to London! #KSRNAMod24

Very proud to have this new collaborative work published in Cell Stem Cell with Bertie Gottgens Donal O'Carroll. We reveal in situ real-time haematopoietic stem and progenitor cell behaviour linked to gene expression patterns, thus unveiling hierarchal dynamics. The ICR Barts Cancer Institute (Queen Mary)

Very sad news for us all, haematology and cancer research. Connie was a truly inspirational leader, mentoring generations of new scientists, and remains one of the most passionate researchers I have ever met. We will miss her dearly!

Very proud of Dr Jozef Durko, who has just passed his PhD viva Barts Cancer Institute (Queen Mary). Many thanks to Keeshan Lab and Rhys Morgan for examining! Best of luck with your move to Iannis Aifantis lab in New York. Jozef is a great young scientist and will be missed in London!

Really enjoyed #EHAReCon2024 conference in Bulgaria with lots of amazing science. Well done to Hannah Lawson for a great talk about the impact of m6A mRNA readers on AML and normal haematopoiesis! European Hematology Association

📰NEWS: Targeting the way that cells sense and adapt to oxygen could offer a new way to treat acute myeloid leukaemia. ICR scientists led by Kamil R Kranc have discovered that existing drugs could be used to treat the aggressive form of #leukaemia. icr.ac.uk/news-archive/s…

🩸JUST 1 DAY TO GO! As we spread awareness of #AcuteMyeloidLeukemia (AML), over the last few days we have been highlighting AML group leaders College of BLS. #KnowAML! Today Prof Richard Darley. Richard co-leads the Cardiff AML Target Discovery and Translation Research Group.

We are looking for a new consultant colleague (10 PA, substantive NHS post). Great opportunity for anyone with an interest in myeloma who wants to join an academic centre. royalmarsden.nhs.uk/current-vacanc…

nature.com/articles/s4146… Delighted we could participate in this amazing study. It shows that the piRNA pathway is central to supporting human male fertility and transposon silencing .

Deadline is approaching. Don’t miss out, apply!!

As always, me, Hannah Lawson and others in my Team The ICR were delighted to collaborate with Paolo Gallipoli and Vilma Dembitz, this time on their study discovering SCD as a potential therapeutic target in AML. Congrats Paolo and the Team!